IDO immunotherapy

Bristol-Myers bags IDO immunotherapy in $1.25B buyout of fledgling Flexus
Fierce Biotech
Mon, 02/23/15 - 09:40 am
Bristol-Myers Squibb
IDO immunotherapy
cancer immunotherapy
Flexus
M&A